Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

PURPOSE: Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded Prognostic Assessment (GPA). Updates with larger...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Sperduto, Paul W., Mesko, Shane, Li, Jing, Cagney, Daniel, Aizer, Ayal, Lin, Nancy U., Nesbit, Eric, Kruser, Tim J., Chan, Jason, Braunstein, Steve, Lee, Jessica, Kirkpatrick, John P., Breen, Will, Brown, Paul D., Shi, Diana, Shih, Helen A., Soliman, Hany, Sahgal, Arjun, Shanley, Ryan, Sperduto, William A., Lou, Emil, Everett, Ashlyn, Boggs, Drexell H., Masucci, Laura, Roberge, David, Remick, Jill, Plichta, Kristin, Buatti, John M., Jain, Supriya, Gaspar, Laurie E., Wu, Cheng-Chia, Wang, Tony J.C., Bryant, John, Chuong, Michael, An, Yi, Chiang, Veronica, Nakano, Toshimichi, Aoyama, Hidefumi, Mehta, Minesh P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2020
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655019/
https://ncbi.nlm.nih.gov/pubmed/32931399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.01255
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak